Basic Information
Deep Genomics Utilizes AI and Machine Learning to Develop and Prioritize Transformative RNA Therapeutic Programs for Any Genetic ConditionThe platform, known as the AI Workbench, enables Deep Genomics to decode vast amounts of RNA biological data, identify new targets for genetically defined diseases, and produce therapies with a high success rate. Nearly everyone will develop a genetically influenced disease at some point in their lives, and Deep Genomics is committed to providing precise gene therapies for them. The platform supports geneticists, molecular biologists, chemists, toxicologists, and drug developers in identifying and developing genetic medicines.
Deep Genomics Inc.
Toronto,Ontario,Canada
101~500 people
January 01, 2014
contact@deepgenomics.com
